Cel-Sci
CVM
#9766
Rank
NZ$89.24 M
Marketcap
NZ$11.16
Share price
2.54%
Change (1 day)
-60.91%
Change (1 year)

Earnings for Cel-Sci (CVM)

Earnings in 2025 (TTM): -NZ$41.89 Million

According to Cel-Sci 's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -NZ$45.99 Million, an increase over its 2023 earnings that were of -NZ$52.51 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Cel-Sci from 1986 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -NZ$41.89 Million-8.92%
2024 -NZ$45.99 Million-12.41%
2023 -NZ$52.51 Million-12.87%
2022 -NZ$60.26 Million-3.42%
2021 -NZ$62.4 Million13.44%
2020 -NZ$55 Million11.28%
2019 -NZ$49.43 Million179.81%
2018 -NZ$17.67 Million-48.72%
2017 -NZ$34.45 Million-16.23%
2016 -NZ$41.12 Million-23.63%
2015 -NZ$53.85 Million-5.47%
2014 -NZ$56.97 Million198.49%
2013 -NZ$19.09 Million
2010 -NZ$22.28 Million
2004 -NZ$7.53 Million12.38%
2003 -NZ$6.7 Million-16.59%
2002 -NZ$8.04 Million-59.28%
2001 -NZ$19.73 Million23.17%
2000 -NZ$16.02 Million20.12%
1999 -NZ$13.33 Million13.24%
1998 -NZ$11.78 Million-20%
1997 -NZ$14.72 Million46.55%
1996 -NZ$10.04 Million34.88%
1995 -NZ$7.45 Million2.38%
1994 -NZ$7.28 Million68%
1993 -NZ$4.33 Million78.57%
1992 -NZ$2.43 Million180%
1991 -NZ$0.87 Million25%
1990 -NZ$0.7 Million-0%
1989 -NZ$0.7 Million-71.43%
1988 -NZ$2.43 Million-0%
1987 -NZ$2.43 Million-46.15%
1986 -NZ$4.51 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Curis
CRIS
-NZ$56.36 Million 31.68%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
-NZ$11.46 Million-73.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$14.27 B-33,443.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
-NZ$0.24 Billion 458.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
NZ$3.06 B-7,266.95%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Johnson & Johnson
JNJ
NZ$56.07 B-131,127.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
NZ$0.28 B-768.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-NZ$16.43 Million-61.62%๐Ÿ‡บ๐Ÿ‡ธ USA